Trial into puberty blockers for children paused over 'wellbeing concerns'

UK Puberty Blocker Trial Halted Over Safety Fears

A controversial NHS-backed trial giving puberty blockers to children as young as eight has been dramatically halted after Britain’s medicines watchdog intervened over safety fears. The Medicines and Healthcare products Regulatory Agency (MHRA) has pressed pause on the Pathways study, warning of potentially “significant” and unquantified long-term harms. Officials are now demanding urgent talks with trial leaders at King’s College London, includi…

Trial into puberty blockers for children paused over 'wellbeing concerns'

Recruitment to the study will be postponed until the issues have been resolved with the sponsor, King's College, and it is concluded that it is "both safe and necessary", a spokesperson for the Department of Health and Social Care.

Puberty blockers trial paused after MHRA raises safety concerns

The medicines regulator is suggesting the minimum age limit for trial should be raised to 14.

Puberty blockers’ clinical trial paused after concerns from regulator

The MHRA will now discuss the concerns, related to the wellbeing of children and young people with gender dysphoria, with trial sponsor King’s College London next week

Clinical trial into puberty blockers paused after ‘new concerns’

It comes after legal action was launched against the Government after campaigners including Harry Potter author JK Rowling expressed their opposition

NHS child puberty blocker trial SUSPENDED after medicines regulator raises new concerns

The National Health Service's puberty blocker trial for children has been suspended after Britain’s medicines regulator raised fresh safety concerns